Concepedia

Jesse W. Huff

JW

Statistics

Publications

45

Citations

5K

H-Index

29

Active since

1942

Affiliations

Duke University(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

United States Military Academy

Jesse W. Huff is an author at Duke University specializing in life sciences, biochemistry, and pharmacology.

Publications per year

1942–2011

45

Publications

45

Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent.

Alfred W. Alberts, J Chen, G. W. Kuron et al. · Proceedings of the National Academy of Sciences · 1980 · 1.6K citations · Full text

Life Sciences, Biochemistry, Pharmacology +17

Bardoxolone Methyl and Kidney Function in CKD with Type 2 Diabetes

Pablo E. Pérgola, Philip Raskin, Robert D. Toto et al. · New England Journal of Medicine · 2011 · 876 citations · Full text

Medicine, Endocrinology, Nephrology +16

Effect of Bardoxolone Methyl on Kidney Function in Patients with T2D and Stage 3b–4 CKD

Pablo E. Pérgola, Melissa Krauth, Jesse W. Huff et al. · American Journal of Nephrology · 2011 · 232 citations · Full text

Medicine, Nephrology, Pharmacology +17

THE FLUORESCENT CONDENSATION PRODUCT OF N1-METHYLNICOTINAMIDE AND ACETONE

Jesse W. Huff, W. A. Perlzweig · Journal of Biological Chemistry · 1947 · 196 citations · Full text

Natural Sciences, Biochemistry, Chemistry +7

THE UTILIZATION OF β-HYDROXY-β-METHYL-δ-VALEROLACTONE IN CHOLESTEROL BIOSYNTHESIS

Peter A. Tavormina, Margaret H. Gibbs, Jesse W. Huff · Journal of the American Chemical Society · 1956 · 186 citations

Life Sciences, Biochemistry, Bioisosterism +8

1–5 of 45